SynthesisMolecular biology reports2026
Toll-like receptors in corneal ectasia: linking innate immunity to keratoconus.
Synthesis in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Clinical manifestations of keratoconus (KC) are well described; however, its exact pathophysiology remains unknown. While KC is typically known as a primarily degenerative disease which progression is accelerated by mechanical trauma, Toll-like receptors (TLRs) have emerged as key contributors to disease development. TLRs are protein receptors that play a crucial role in the body's innate immune response. This systematic review was carried out using Web of Science, Scopus, MEDLINE, and EMBASE databases up to May 2025 to investigate TLRs expression in KC and corneal ectasia. These studies suggest a potential role of TLR2 and TLR4 in the early diagnosis and therapeutic management of corneal ectasia. Nevertheless, further studies are required to clarify the precise dynamics and clinical effects of TLRs in corneal ectasia.
Indexed as
Identifiers
42262402What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.